Rasmussen encephalitis is a chronic inflammatory disease that results in progressive degeneration of one cerebral hemisphere. Immunotherapies for this condition have traditionally targeted T-cell-mediated immunity, but Thilo et al. now report a case in which effective seizure control was achieved through use of the anti-B-cell antibody rituximab.
- Barbara Thilo
- Robert Stingele
- Nicolas Lang
